AxoGen Coverage Initiated by Analysts at Dawson James (AXGN)
Research analysts at Dawson James assumed coverage on shares of AxoGen (NASDAQ:AXGN) in a report released on Wednesday, AnalystRatings.NET reports. The firm set a “buy” rating and a $5.00 price target on the stock. Dawson James’ price objective would indicate a potential upside of 92.31% from the stock’s previous close.
Shares of AxoGen (NASDAQ:AXGN) remained flat at $2.60 during trading on Wednesday. The stock had a trading volume of 165,817 shares. AxoGen has a 52-week low of $2.42 and a 52-week high of $5.20. The stock’s 50-day moving average is $2.82 and its 200-day moving average is $3.71. The company’s market cap is $45.4 million.
AxoGen (NASDAQ:AXGN) last announced its earnings results on Wednesday, April 30th. The company reported ($0.24) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.23) by $0.01. On average, analysts predict that AxoGen will post $-0.89 earnings per share for the current fiscal year.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.